SightfileU.S. market data from official filings

Companies › RIGL

RIGEL PHARMACEUTICALS INC (RIGL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001034842 · EDGAR filings · Updated 2026-07-10

RIGEL PHARMACEUTICALS INC (RIGL) has reported institutional ownership of 85.9%, with 148 institutional managers holding positions valued at $429.6M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
85.9%
Institutional managers
148
Reported 13F value
$429.6M
Insider activity
29 trans.
−$145.4K net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, RIGEL PHARMACEUTICALS INC has 148 institutional holders and institutional ownership of 85.9%.

Insider activity

Insiders reported 29 transactions (0 buys, 1 sells) across 12 reporting insiders, with a net reported value of −$145.4K.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-11-30 (recurring since 2022-11-29) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ABCELLERA BIOLOGICS INC (ABCL) · DBV TECHNOLOGIES S A (DBVT) · VERASTEM INC (VSTM) · TECTONIC THERAPEUTIC INC (TECX) · ACLARIS THERAPEUTICS (ACRS) · UPSTREAM BIO INC (UPB)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.